•
LL
LLY
Eli Lilly & Co.
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
931.97B
Volume
3.69M
52W High
$1,133.95
52W Low
$623.78
Open
$1,043.86
Prev Close
$1,041.29
Day Range
1,042.02 - 1,081.33
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Latest News
Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc.•7h ago
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
The Motley Fool•Yesterday
3 Biotech Stocks to Keep an Eye on in 2026
Investing.com•Yesterday
Down 55%, Should You Buy the Dip on Pfizer?
The Motley Fool•Jan 19
Prediction: 2026 Will Be the Year of Eli Lilly
The Motley Fool•Jan 19
Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica
GlobeNewswire Inc.•Jan 16
FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)
Benzinga•Jan 16
InSilico Lands Drug Discovery Deal After Hong Kong IPO
Benzinga•Jan 15